{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:15:44Z","timestamp":1788322544736,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijrobp.2026.08.038","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:52:28Z","timestamp":1787669548000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Executive Summary of the American Radium Society Appropriate Use Criteria for a Multidisciplinary Treatment Approach to the Management of Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3230-1815","authenticated-orcid":false,"given":"Christopher J.","family":"Anker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Juloori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Chamil Codipilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Percy","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishan R.","family":"Jethwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Eva Selfridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Abood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitriy","family":"Akselrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Attallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Donington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Dozios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Hallemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneeth","family":"Iyengar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma K.","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane C.","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil B.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rimner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navesh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence T.","family":"Sio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben J.","family":"Slotman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"William","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randa","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Tchelebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Charles B.","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijrobp.2026.08.038_bib0001","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijrobp.2020.08.050","article-title":"Executive Summary of the American Radium Society Appropriate Use Criteria for Operable Esophageal and Gastroesophageal Junction Adenocarcinoma: Systematic Review and Guidelines","volume":"109","author":"Anker","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"18","key":"10.1016\/j.ijrobp.2026.08.038_bib0002","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1200\/JCO.20.03614","article-title":"Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial","volume":"39","author":"Eyck","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.08.038_bib0003","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ijrobp.2026.08.038_bib0004","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ijrobp.2026.08.038_bib0005","unstructured":"Fitch K, Bernsein S, Aguilar M. The RAND\/UCLA Appropriateness Method User\u2019s Manual. 2021."},{"key":"10.1016\/j.ijrobp.2026.08.038_bib0006","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijsu.2018.01.008","article-title":"Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials","volume":"51","author":"Coccolini","year":"2018","journal-title":"Int J Surg"},{"issue":"5","key":"10.1016\/j.ijrobp.2026.08.038_bib0007","article-title":"Preoperative chemotherapy for resectable thoracic esophageal cancer","volume":"2015","author":"Kidane","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"30","key":"10.1016\/j.ijrobp.2026.08.038_bib0008","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1200\/JCO.2009.22.2083","article-title":"Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer","volume":"27","author":"Allum","year":"2009","journal-title":"J Clin Oncol"},{"issue":"27","key":"10.1016\/j.ijrobp.2026.08.038_bib0009","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJM199812313392704","article-title":"Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer","volume":"339","author":"Kelsen","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ijrobp.2026.08.038_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.08.038_bib0011","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejca.2020.06.005","article-title":"Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03)","volume":"137","author":"Athauda","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2026.08.038_bib0012","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejca.2022.04.026","article-title":"Neoadjuvant chemotherapy improves survival in patients with oesophageal mucinous adenocarcinoma: Post-hoc analysis of the UK MRC OE02 and OE05 trials","volume":"170","author":"Liu","year":"2022","journal-title":"Eur J Cancer"},{"issue":"23","key":"10.1016\/j.ijrobp.2026.08.038_bib0013","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1200\/JCO.2013.53.6532","article-title":"Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901","volume":"32","author":"Mariette","year":"2014","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ijrobp.2026.08.038_bib0014","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ijrobp.2026.08.038_bib0015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.2017.73.7718","article-title":"Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial","volume":"36","author":"Noordman","year":"2018","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ijrobp.2026.08.038_bib0016","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/bjs.11246","article-title":"Health-related quality of life in a randomized trial of neoadjuvant chemotherapy or chemoradiotherapy plus surgery in patients with oesophageal cancer (NeoRes trial)","volume":"106","author":"Sunde","year":"2019","journal-title":"Br J Surg"},{"issue":"12","key":"10.1016\/j.ijrobp.2026.08.038_bib0017","doi-asserted-by":"crossref","first-page":"20410","DOI":"10.18632\/oncotarget.14669","article-title":"Concurrent neoadjuvant chemoradiotherapy could improve survival outcomes for patients with esophageal cancer: a meta-analysis based on random clinical trials","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.ijrobp.2026.08.038_bib0018","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/annonc\/mdt339","article-title":"A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer","volume":"24","author":"Ajani","year":"2013","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ijrobp.2026.08.038_bib0019","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/bjc.2017.423","article-title":"Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial","volume":"118","author":"Shimodaira","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2026.08.038_bib0020","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejca.2021.03.025","article-title":"Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance])","volume":"150","author":"Yoon","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2026.08.038_bib0021","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejca.2021.05.020","article-title":"Oxaliplatin\/capecitabine or carboplatin\/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial","volume":"153","author":"Mukherjee","year":"2021","journal-title":"Eur J Cancer"},{"issue":"25","key":"10.1016\/j.ijrobp.2026.08.038_bib0022","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1200\/JCO.20.03611","article-title":"Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial","volume":"39","author":"Goodman","year":"2021","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ijrobp.2026.08.038_bib0023","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1470-2045(21)00718-X","article-title":"Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology\/RTOG 1010): a multicentre, randomised, phase 3 trial","volume":"23","author":"Safran","year":"2022","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ijrobp.2026.08.038_bib0024","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa2409408","article-title":"Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer","volume":"392","author":"Hoeppner","year":"2025","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ijrobp.2026.08.038_bib0025","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.annonc.2019.10.019","volume":"31","author":"Barbour","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2026.08.038_bib0026","article-title":"Definitive chemoradiotherapy plus cetuximab for cancer in the oesophagus or gastro-oesophageal junction","volume":"24","author":"von Dobeln","year":"2020","journal-title":"Cancer Treat Res Commun"},{"issue":"2","key":"10.1016\/j.ijrobp.2026.08.038_bib0027","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doy069","article-title":"Effects of neoadjuvant chemoradiotherapy vs chemotherapy alone on the relief of dysphagia in esophageal cancer patients: secondary endpoint analysis in a randomized trial","volume":"32","author":"Sunde","year":"2019","journal-title":"Dis Esophagus"},{"issue":"3","key":"10.1016\/j.ijrobp.2026.08.038_bib0028","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ejca.2010.09.009","article-title":"Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial","volume":"47","author":"Burmeister","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2026.08.038_bib0029","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejca.2017.04.027","article-title":"Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial","volume":"81","author":"Stahl","year":"2017","journal-title":"Eur J Cancer"},{"issue":"10184","key":"10.1016\/j.ijrobp.2026.08.038_bib0030","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ijrobp.2026.08.038_bib0031","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S2468-1253(23)00243-1","article-title":"Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial","volume":"8","author":"Reynolds","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"19","key":"10.1016\/j.ijrobp.2026.08.038_bib0032","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa2405195","article-title":"Preoperative Chemoradiotherapy for Resectable Gastric Cancer","volume":"391","author":"Leong","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ijrobp.2026.08.038_bib0033","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.34495","article-title":"Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II\/III trial of the German AIO and Italian GOIM","volume":"153","author":"Goetze","year":"2023","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ijrobp.2026.08.038_bib0034","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10120-022-01335-4","article-title":"Pertuzumab, trastuzumab, and chemotherapy in HER2-positive gastric\/gastroesophageal junction cancer: end-of-study analysis of the JACOB phase III randomized clinical trial","volume":"26","author":"Tabernero","year":"2023","journal-title":"Gastric Cancer"},{"issue":"2","key":"10.1016\/j.ijrobp.2026.08.038_bib0035","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(23)00541-7","article-title":"Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study","volume":"25","author":"Shitara","year":"2024","journal-title":"Lancet Oncol"},{"issue":"20","key":"10.1016\/j.ijrobp.2026.08.038_bib0036","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.2217\/fon-2022-0093","article-title":"MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric\/gastroesophageal junction cancer","volume":"18","author":"Janjigian","year":"2022","journal-title":"Future Oncol"},{"issue":"13","key":"10.1016\/j.ijrobp.2026.08.038_bib0037","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer","volume":"384","author":"Kelly","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ijrobp.2026.08.038_bib0038","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.annonc.2024.10.829","volume":"36","author":"Lordick","year":"2025","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ijrobp.2026.08.038_bib0039","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.annonc.2020.11.004","article-title":"Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial","volume":"32","author":"de Steur","year":"2021","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ijrobp.2026.08.038_bib0040","first-page":"45","article-title":"Longitudinal Quality-of-Life Analysis of RTOG 94-05 (Int 0123):A Phase III Trial of Definitive Chemoradiotherapy for Esophageal Cancer","volume":"4","author":"Kachnic","year":"2011","journal-title":"Gastrointest Cancer Res"},{"issue":"5","key":"10.1016\/j.ijrobp.2026.08.038_bib0041","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.2002.20.5.1167","article-title":"INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy","volume":"20","author":"Minsky","year":"2002","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.ijrobp.2026.08.038_bib0042","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","article-title":"Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group","volume":"281","author":"Cooper","year":"1999","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ijrobp.2026.08.038_bib0043","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jamaoncol.2017.1598","article-title":"Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial","volume":"3","author":"Suntharalingam","year":"2017","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.ijrobp.2026.08.038_bib0044","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(25)00027-0","article-title":"Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial","volume":"26","author":"van der Wilk","year":"2025","journal-title":"Lancet Oncol"},{"issue":"25","key":"10.1016\/j.ijrobp.2026.08.038_bib0045","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1200\/JCO.20.03697","article-title":"Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study)","volume":"39","author":"Hulshof","year":"2021","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626042227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626042227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:37:49Z","timestamp":1788320269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626042227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":45,"alternative-id":["S0360301626042227"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.08.038","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Executive Summary of the American Radium Society Appropriate Use Criteria for a Multidisciplinary Treatment Approach to the Management of Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.08.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}